Sorry, but this entry has me flummoxed. Mesoblast has never been involved in research on sepsis as far as I know. It has also limited its focus to its Tier 1 products. Why do you think that it should branch out into sepsis research ? Treatments for sepsis already exist but not, to my knowledge in the expensive and slow acting stem cell area. Correct me if i am wrong?
Sepsis... quickest way to prove Stem cell efficacy, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $2.475M | 2.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 65290 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 44322 | 6 |
View Market Depth
| Last trade - 12.07pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |